Detectable A Disintegrin and Metalloproteinase With Thrombospondin Motifs-1 in Serum Is Associated With Adverse Outcome in Pediatric Sepsis

Supplemental Digital Content is available in the text. IMPORTANCE: A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 is hypothesized to play a role in the pathogenesis of invasive infection, but studies in sepsis are lacking. OBJECTIVES: To study A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 protein level in pediatric sepsis and to study the association with outcome. DESIGN: Data from two prospective cohort studies. SETTING AND PARTICIPANTS: Cohort 1 is from a single-center study involving children admitted to PICU with meningococcal sepsis (samples obtained at three time points). Cohort 2 includes patients from a multicenter study involving children admitted to the hospital with invasive bacterial infections of differing etiologies (samples obtained within 48 hr after hospital admission). MAIN OUTCOMES AND MEASURES: Primary outcome measure was mortality. Secondary outcome measures were PICU-free days at day 28 and hospital length of stay. RESULTS: In cohort 1 (n = 59), nonsurvivors more frequently had A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels above the detection limit than survivors at admission to PICU (8/11 [73%] and 6/23 [26%], respectively; p = 0.02) and at t = 24 hours (2/3 [67%] and 3/37 [8%], respectively; p = 0.04). In cohort 2 (n = 240), A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels in patients within 48 hours after hospital admission were more frequently above the detection limit than in healthy controls (110/240 [46%] and 14/64 [22%], respectively; p = 0.001). Nonsurvivors more often had detectable A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels than survivors (16/21 [76%] and 94/219 [43%], respectively; p = 0.003), which was mostly attributable to patients with Neisseria meningitidis. CONCLUSIONS AND RELEVANCE: In children with bacterial infection, detection of A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 within 48 hours after hospital admission is associated with death, particularly in meningococcal sepsis. Future studies should confirm the prognostic value of A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 and should study pathophysiologic mechanisms.

[1]  Colin G Fink,et al.  Identification of regulatory variants associated with genetic susceptibility to meningococcal disease , 2019, Scientific Reports.

[2]  S. Apte,et al.  ADAMTS proteins in human disorders. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[3]  P. Anderson,et al.  ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response , 2018, Scientific Reports.

[4]  G. Driessen,et al.  Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study. , 2018, The Lancet. Child & adolescent health.

[5]  Colin G Fink,et al.  Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS) , 2018, Critical Care.

[6]  I. Sjaastad,et al.  Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice. , 2015, Journal of molecular and cellular cardiology.

[7]  M. Levi,et al.  How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines , 2015, Journal of immunology research.

[8]  Richard J. R. Kelwick,et al.  The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family , 2015, Genome Biology.

[9]  S. Opal,et al.  Sepsis: a roadmap for future research. , 2015, The Lancet. Infectious diseases.

[10]  E. Medina,et al.  The role of coagulation/fibrinolysis during Streptococcus pyogenes infection , 2014, Front. Cell. Infect. Microbiol..

[11]  A. Zhang,et al.  Associations between interleukin-1 gene polymorphisms and sepsis risk: a meta-analysis , 2014, BMC Medical Genetics.

[12]  J. Hazelzet,et al.  Decreased Expression of Serum and Microvascular Vascular Endothelial Growth Factor Receptor-2 in Meningococcal Sepsis* , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[13]  Hong-ping Qu,et al.  The angiogenic factors and their soluble receptors in sepsis: friend, foe, or both? , 2013, Critical Care.

[14]  L. Coin,et al.  A new scoring system derived from base excess and platelet count at presentation predicts mortality in paediatric meningococcal sepsis , 2013, Critical Care.

[15]  H. Wiig,et al.  Proteomic evaluation of inflammatory proteins in rat spleen interstitial fluid and lymph during LPS-induced systemic inflammation reveals increased levels of ADAMST1. , 2012, Journal of proteome research.

[16]  S. Apte.  A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms* , 2009, The Journal of Biological Chemistry.

[17]  T. Alonzo,et al.  Disseminated intravascular coagulation score is associated with mortality for children with shock , 2009, Intensive Care Medicine.

[18]  E. Ruokonen,et al.  Vascular Endothelial Growth Factor in Severe Sepsis and Septic Shock , 2008, Anesthesia and analgesia.

[19]  L. Trinquart,et al.  Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure* , 2007, Critical care medicine.

[20]  Javed Siddiqui,et al.  Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality1 , 2006, The Journal of Immunology.

[21]  P. Leung,et al.  Differential effects of interleukin-1beta and transforming growth factor-beta1 on the expression of the inflammation-associated protein, ADAMTS-1, in human decidual stromal cells in vitro. , 2006, Human reproduction.

[22]  P. Carmeliet,et al.  Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality , 2006, The Journal of experimental medicine.

[23]  P. Pickkers,et al.  VASCULAR ENDOTHELIAL GROWTH FACTOR IS INCREASED DURING THE FIRST 48 HOURS OF HUMAN SEPTIC SHOCK AND CORRELATES WITH VASCULAR PERMEABILITY , 2005, Shock.

[24]  D. Edwards,et al.  The ADAMTS metalloproteinases. , 2005, The Biochemical journal.

[25]  J. Kimpen,et al.  PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR IN SEVERE SEPSIS , 2005, Shock.

[26]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[27]  M. Iruela-Arispe,et al.  ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165* , 2003, Journal of Biological Chemistry.

[28]  P. Mulder,et al.  Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. , 2003, Critical care medicine.

[29]  F. Shann,et al.  PIM2: a revised version of the Paediatric Index of Mortality , 2003, Intensive Care Medicine.

[30]  F B Taylor,et al.  Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.

[31]  K. Fujikawa,et al.  Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. , 2001, Blood.

[32]  M. Sasaki,et al.  A disintegrin and metalloprotease with thrombospondin type1 motifs (ADAMTS-1) and IL-1 receptor type 1 mRNAs are simultaneously induced in nerve injured motor neurons. , 2001, Brain research. Molecular brain research.

[33]  M. Hibberd,et al.  4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease , 1999, The Lancet.

[34]  M. Iruela-Arispe,et al.  METH-1, a Human Ortholog of ADAMTS-1, and METH-2 Are Members of a New Family of Proteins with Angio-inhibitory Activity* , 1999, The Journal of Biological Chemistry.

[35]  J. Wittes,et al.  Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  W. Hop,et al.  Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  K. Matsushima,et al.  Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene* , 1997, The Journal of Biological Chemistry.

[38]  U. Ruttimann,et al.  Pediatric risk of mortality (PRISM) score. , 1988, Critical care medicine.

[39]  J. Hazelzet,et al.  Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome , 2010, Thrombosis and Haemostasis.

[40]  M. Iruela-Arispe,et al.  ADAMTS 1 / METH 1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF 165 * , 2003 .

[41]  C. Gogos,et al.  Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. , 2000, The Journal of infectious diseases.